Sarah Wollaston Chair, Health and Social Care Committee, Chair, Liaison Committee (Commons)
Further to the point made by Ian Austin, we know that the UK is a world leader in research into rare conditions, but that does not always translate into timely access to those treatments. The Secretary of State will know that there are many CFTR—cystic fibrosis transmembrane conductance regulator—treatments in the pipeline that could benefit people who are living with cystic fibrosis. Will he meet me to see how we can ensure that those are available in a timely manner for the people who desperately need them?
Jeremy Hunt Secretary of State for Health and Social Care
Of course I am happy to meet my hon. Friend. I recognise that this is one of the things that we are not good at at the moment. We have fantastic research, with amazing new drugs developed in this country, but our uptake can be painfully slow, and that is of course something that we want to put right.
If you would like to see full details of what's on in Parliament this week, you can do so via the Parliament website.
This will take you to all of my written and spoken material by date